We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine ...

A science fair — of sorts — is slated for the Manitoba Legislative Building this March. But instead of high school students, major medicine-producing companies will set up booths, showcasing their ...

Cathie Wood's ARK sold $2.78M Twist Bioscience, bought Tempus AI & WeRide Jan 26. Full breakdown of ARK Invest's latest AI ...

The Phase I/II study will enrol approximately 368 adults aged 18 years and above.

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo Th ...

The City of Charlottetown is considering adding a second business improvement area in the province's capital city.

The Seahawks will eventually be sold by Jody Allen, the current team chair who took over in that role when her brother, Paul ...

Lexaria now has 60 patents granted around much of the worldLexaria urges shareholders to vote at upcoming 2026 Annual Meeting KELOWNA, BC / ACCESS Newswire / January 22, 2026 / Lexaria Bioscience Corp ...

Tru Niagen features Niagen, the most efficient and high-quality NAD+ booster available, backed by more than 40 peer-reviewed human clinical studies. Niagen Bioscience holds a robust intellectual ...

They form the backbone of social media platforms, e-commerce sites and other technologies. They pay big tax bills but suck up energy and water.